Status:

COMPLETED

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma

Lead Sponsor:

Ann & Robert H Lurie Children's Hospital of Chicago

Conditions:

Brain Stem Neoplasms, Primary

Neoplasms, Brain Stem

Eligibility:

All Genders

3-21 years

Phase:

PHASE2

Brief Summary

Treatment on this study combines two drugs: Thalomid™ (thalidomide) and carboplatin. Thalidomide has been available for many years and has been used to treat many different illnesses. Carboplatin is a...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients must be \>/= 3 and \</= 21 years of age.
  • Patients must have a newly diagnosed or progressive brain stem tumor.
  • If biopsy has been performed, patients with both high and low grade astrocytomas are eligible.
  • Non-histologically confirmed brain stem tumors are eligible. Neuroradiographic confirmation of brain stem glioma is mandatory for study entry.
  • Cervicomedullary junction tumors are ineligible.
  • Patients with a diagnosis of NF-1 are ineligible.
  • Patients must be registered within 6 weeks from diagnosis or recurrence.
  • Patients must have life expectancy \> 6 weeks.
  • Patients must have adequate hematologic and renal function: ANC \>1,000/ul, platelets\>100,000/ul and creatinine normal for age: \</= 0.7 mg/dl (age 3-10yrs.), \</= 1.0 mg/dl (11-12yrs.). and \</= 1.2 (13-21yrs.).
  • Written informed consent must be obtained according to institutional guidelines.
  • Pregnant or nursing women are ineligible.
  • Patients must be registered within 3 days prior to the start of protocol treatment. Patients must not start treatment until informed consent is given and the patient is registered. Willingness and ability to comply with the FDA-mandated S.T.E.P.S.® program.

Exclusion

    Key Trial Info

    Start Date :

    December 1 1999

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2007

    Estimated Enrollment :

    47 Patients enrolled

    Trial Details

    Trial ID

    NCT00179881

    Start Date

    December 1 1999

    End Date

    April 1 2007

    Last Update

    February 5 2019

    Active Locations (6)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (6 locations)

    1

    Phoenix Children's Hospital

    Phoenix, Arizona, United States, 85016

    2

    Children's Memorial Hospital

    Chicago, Illinois, United States, 60614

    3

    Children's Hospitals and Clinics

    Minneapolis, Minnesota, United States, 55404

    4

    Children's Hospitals and Clinics

    Saint Paul, Minnesota, United States, 55404